Holen Sie sich die Stockscreener-App
0.204
1.26%
-0.0026
Finanzdaten der Vistagen Therapeutics Inc-Aktie (VTGN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
217.42%
1.476
|
0.465 | 0.303 | 0.258 | 0.244 |
| Operating Expenses |
13.72%
14.82
|
17.18 | 19.85 | 20.31 | 16.05 |
| Operating Income/Loss |
20.15%
-13.35
|
-16.72 | -19.55 | -20.05 | -15.80 |
| Income/Loss From Continuing Operations Before Tax |
19.90%
-13.03
|
-16.27 | -18.90 | -19.42 | -15.10 |
| Income Tax Expense/Benefit |
100.00%
-
|
0.007 | - | - | - |
| Net Income/Loss |
19.93%
-13.03
|
-16.27 | -18.90 | -19.42 | -15.10 |
| Basic Average Shares |
42.98
|
- | 42.23 | 35.75 | 31.93 |
| Diluted Average Shares |
42.98
|
- | 42.23 | 35.75 | 31.93 |
| Basic Earnings Per Share |
-0.30
|
- | -0.45 | -0.54 | -0.47 |
| Diluted Earnings Per Share |
-0.30
|
- | -0.45 | -0.54 | -0.47 |
2.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):